Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Expert Opinion on Therapeutic Patents|May 29, 2009
C-9 Alkenylidine bridged macrolides: WO2008061189. Enanta Pharmaceuticals, IncGiovanna Poce, Giulio Cesare Porretta, Mariangela Biava
Bioorganic & Medicinal Chemistry|March 17, 2004
Antimycobacterial compounds. New pyrrole derivatives of BM212Mariangela Biava, Giulio Cesare Porretta, Delia Deidda, et al.
Bioorganic & Medicinal Chemistry|January 23, 2003
Importance of the thiomorpholine introduction in new pyrrole derivatives as antimycobacterial agents analogues of BM 212Mariangela Biava, Giulio Cesare Porretta, Delia Deidda, et al.
Bioorganic & Medicinal Chemistry|January 27, 2005
Antimycobacterial compounds. Optimization of the BM 212 structure, the lead compound for a new pyrrole derivative classMariangela Biava, Giulio Cesare Porretta, Giovanna Poce, et al.
Chemmedchem|February 23, 2011
Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approachMariangela Biava, Giulio Cesare Porretta, Giovanna Poce, et al.
Journal of Medicinal Chemistry|August 4, 2006
Antimycobacterial agents. Novel diarylpyrrole derivatives of BM212 endowed with high activity toward Mycobacterium tuberculosis and low cytotoxicityMariangela Biava, Giulio Cesare Porretta, Giovanna Poce, et al.
Journal of Medicinal Chemistry|May 23, 2008
1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl ringsMariangela Biava, Giulio Cesare Porretta, Giovanna Poce, et al.
Journal of Medicinal Chemistry|April 29, 2005
1,5-Diarylpyrrole-3-acetic acids and esters as novel classes of potent and highly selective cyclooxygenase-2 inhibitorsMariangela Biava, Giulio Cesare Porretta, Andrea Cappelli, et al.
Chirality|January 18, 2008
HPLC enantioseparation and absolute configuration of novel anti-inflammatory pyrrole derivativesMariangela Biava, Roberto Cirilli, Vincenzo Fares, et al.
Pageof 2